The expression of CCL2 was increased in LPS-treated CT-26 (mouse colon cancer cell) (Shi et al., 2019), which was consistent with our study that CCL2 expression was up-regulated in inflammatory states. The gene discussed is CCL2; the disease is malignant colon neoplasm.